In an era where trade secret misappropriation battles can shape corporate landscapes, the Apple v. Rivos case stands as a stark reminder of the importance of diligent onboarding practices when it comes to trade secrets.  In this case, the court’s scrutiny of employee conduct underscores a crucial lesson: companies should ensure that new hires refrain from carrying confidential information from their previous employers. As exemplified by defendant Rivos, making an effort to remind new hires to avoid retaining confidential information can also go a long way.Here, we discuss the intricacies of the Apple v. Rivos case and provide several takeaways.

Background

The conflict emerged in 2022 when Apple accused former employees, who had joined Rivos, of misappropriating proprietary system-on-a-chip (“SoC”) design information. Rivos is a “stealth-mode” startup—a company that operates in a low-profile, secretive manner, keeping its innovations and developments under wraps until launch—founded to design and market SoCs.  At the time Apple filed its complaint, nearly fifty of its employees had left to join Rivos. 

Apple’s complaint included claims for trade secret misappropriation under the Defend Trade Secrets Act (DTSA) against Rivos and several of Apples former employees as well as claims for breach of contract against the former employees for retaining confidential information after termination of their employment with Apple. In response, Rivos and the former employees counterclaimed that Apple employed illegal measures to intimidate employees contemplating leaving the company in violation of Section 17200 of the California Business and Professional Code.

Legal Developments

The legal landscape shifted significantly when U.S. District Judge Edward Davila granted in part defendants’ motion to dismiss for failure to state a claim. With respect to Apple’s trade secret claims against Rivos the Court found that Apple had not sufficiently alleged how the misappropriation by these former employees could be imputed to Rivos or how Rivos ratified such misappropriation. To this end, the court noted that Apple itself alleged that Rivos’s CEO had advised the former employees not to retain Apple’s confidential information.

The court also dismissed Apple’s trade secret claims against two former employees on grounds that, as pled, misappropriation could not be inferred from the mere fact that they had retained access to Apple information on their synced drives. The Court also dismissed the breach of contract claims against one of those two former employees, finding Apple’s allegations too nebulous—i.e., lacking any allegations as to when he saved the information to his drives or how he was still able to access those drives.  In contrast, the court let stand Apple’s breach of contract claim against the other of the two former employees.

Despite setbacks, the court also found Apple plausibly alleged trade secrets misappropriation and breach of contract against the remaining employees.  The Court found that the transfer of confidential information by each of those employees, shortly before joining Rivos, supported an inference that those individual defendants threatened misappropriation. The Court also permitted Apple to file a revised complaint with respect to the dismissed claims. 

Recent Developments

Since the court’s decision on the motion to dismiss, Apple and the six former employee defendants dropped all claims against each other.  As part of the resolution, the former employees agreed to refrain from accessing, using, or disclosing Apple’s trade secrets. Consequently, only Apple and Rivos remain parties in case. The case is currently stayed to allow the parties to explore the possibility of settlement. Apple v. Rivos, 22-cv-2637, D.I. 387 (N.D. Cal. Jan 10, 2024) (Order granting Stipulation Staying Case).

Takeaways

  • The court’s distinction between employees that transferred confidential information shortly before joining Rivos and those that simply continued to have access to confidential information underscores, in certain circumstances, that merely alleging accessibility to confidential information may not necessarily imply misappropriation, even where continued access would constitute a breach of contract.
  • The court’s finding that Apple did not sufficiently allege how the misappropriation could be imputed to Rivos reveals the complexities in establishing a connection between the misappropriation of individual employees and a corporation. This highlights the need for laying out a factual connection attributing an employee’s misappropriation to its new employer.
  • The court’s scrutiny of how Rivos could be implicated or ratified the alleged misappropriation highlights the importance of advising new employees against retaining the confidential information of their previous employer.  In a situation where allegations as to the new employer company’s conduct may not be entirely clear, this sort of evidence has the potential to turn the tides.
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Edward Wang Edward Wang

As a litigation associate, Eddie Wang focuses his practice on complex commercial and intellectual property matters with an emphasis on patents, trademarks, and trade secrets. He has experience litigating a broad range of technologies including mobile applications, cellular technology, digital televisions, video codecs…

As a litigation associate, Eddie Wang focuses his practice on complex commercial and intellectual property matters with an emphasis on patents, trademarks, and trade secrets. He has experience litigating a broad range of technologies including mobile applications, cellular technology, digital televisions, video codecs, and fuel cells. In addition to commercial litigation and intellectual property, Eddie also leverages his technical background in privacy and cybersecurity matters.

Before practicing law, Eddie worked as a Patent Examiner at the United States Patent and Trademark Office (USPTO) for nearly six years. While there, he examined patents related to memory for electrical computers and digital processing systems.

Photo of Baldassare Vinti Baldassare Vinti

Baldassare (“Baldo”) Vinti is the head of Proskauer’s Intellectual Property Litigation Group.

Baldo is a first-chair trial lawyer known for navigating complex, bet-the-company intellectual property disputes across industry verticals and next-generation technologies. With over 25 years of experience, Baldo represents leading global companies…

Baldassare (“Baldo”) Vinti is the head of Proskauer’s Intellectual Property Litigation Group.

Baldo is a first-chair trial lawyer known for navigating complex, bet-the-company intellectual property disputes across industry verticals and next-generation technologies. With over 25 years of experience, Baldo represents leading global companies and universities in patent, trade secret, false advertising, consumer class actions and technology-related breach of contract litigation in federal and state courts as well as before the International Trade Commission.

Baldo is particularly sought after for his courtroom skill and strategic depth, having led trials, arbitrations and appeals in high-stakes disputes involving technologies ranging from pharmaceuticals and medical devices to encryption, digital media, diagnostics, mobile platforms and software. Baldo has represented global corporations, including Arkema S.A., British Telecommunications PLC, Church & Dwight Co., Inc., Henry Schein, Inc., Maidenform Brands Inc., Mitsubishi Electric Corp., Ossur North America Inc., Panasonic Corp., Sony Corp., Welch Foods, Inc. and Zenith Electronics LLC.

With a background in pharmacy, Baldo brings deep domain expertise to pharmaceutical litigation. He has a proven record of driving successful outcomes in complex pharmaceutical milestone payment, royalty and licensing disputes—often stemming from collaboration agreements, co-development deals, and M&A transactions—where the financial and strategic stakes run high.

In addition to representing corporate clients, Baldo works closely with university innovation and technology transfer offices to maximize the financial return of research investments. He develops tailored IP asset optimization strategies and aggressively enforces intellectual property rights to protect and monetize core innovations—whether through high-value licensing agreements, shaping and advancing spin-out company development, or successful litigation.

Baldo also provides strategic counsel on IP due diligence, complex licensing, IP structuring, patentability and freedom-to-operate analyses, and infringement and validity opinions. He advises boards and executive teams on aligning IP strategy with business objectives, mitigating risk and maximizing the value of innovation assets.

A frequent author and commentator on intellectual property topics, Baldo has been quoted in the National Law Journal, Bloomberg BNA, Law360, Westlaw Journal and Inside Counsel magazine. He is also a regular contributor to articles published in Medical Product Outsourcing magazine that deal with the medical device industry.

Baldo served as a judicial intern for Hon. John E. Sprizzo of the United States District Court for the Southern District of New York and for Hon. Charles A. LaTorella of the New York Supreme Court.